Cutting edge: FADD is not required for antigen receptor-mediated NF-kappaB activation

J Immunol. 2005 Dec 15;175(12):7800-4. doi: 10.4049/jimmunol.175.12.7800.

Abstract

Recently, it has been demonstrated that stimulated T cells bearing defects in caspase-8 fail to promote nuclear shuttling of NF-kappaB complexes. Such cells display strikingly similar proliferative and survival defects as T cells lacking Fas-associated death domain protein (FADD) function. We characterized NF-kappaB signaling in T cells bearing a dominant-negative FADD transgene (FADDdd). Whereas FADDdd T cells displayed proliferative defects following activation, these were not a consequence of aberrant NF-kappaB signaling, as measured by IKK/IkappaB phosphorylation and IkappaB degradation. There were no appreciable defects in nuclear translocation of p65/Rel using ImageStream, a flow-based imaging cytometer. Pretreatment with benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, a potent caspase inhibitor, also failed to impede canonical NF-kappaB signaling. Secretion of IL-2 and up-regulation of various activation markers occurred normally. Thus, FADD does not play an essential role in NF-kappaB activation, suggesting an alternative route by which this adaptor promotes the clonal expansion of T cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Active Transport, Cell Nucleus
  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / physiology*
  • Animals
  • Cell Proliferation
  • Cells, Cultured
  • Clone Cells
  • Fas-Associated Death Domain Protein
  • Humans
  • Lymphocyte Activation
  • Mice
  • Mice, Transgenic
  • Receptors, Antigen, T-Cell / metabolism*
  • Receptors, Antigen, T-Cell / physiology
  • Signal Transduction
  • T-Lymphocytes / physiology
  • Transcription Factor RelA / metabolism*

Substances

  • Adaptor Proteins, Signal Transducing
  • FADD protein, human
  • Fadd protein, mouse
  • Fas-Associated Death Domain Protein
  • Receptors, Antigen, T-Cell
  • Transcription Factor RelA